|
May 13
|
Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript
|
|
May 11
|
Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 44% Below Their Intrinsic Value Estimate
|
|
May 11
|
Guardant Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 10
|
Guardant Health Inc (GH) Reports Strong Q1 2024 Earnings, Surpasses Revenue Estimates
|
|
May 9
|
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
|
|
May 9
|
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 9
|
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
|
|
May 7
|
Guardant Health to Participate in Upcoming Investor Conferences
|
|
May 7
|
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
|
|
May 7
|
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
|
|
May 6
|
Curious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Apr 22
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
|
Apr 22
|
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
|
|
Apr 18
|
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
|
|
Apr 3
|
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
|
|
Apr 2
|
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
|
|
Apr 1
|
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
|
|
Mar 30
|
20 Foods To Reduce Cancer Risk
|
|
Mar 13
|
A blood test for colon cancer performed well in a study, expanding options for screening
|
|
Mar 13
|
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
|